Fatal case of community-acquired empyema thoracis and candidemia caused by Candida albicans

Diagn Microbiol Infect Dis. 2011 Oct;71(2):156-8. doi: 10.1016/j.diagmicrobio.2011.06.008. Epub 2011 Jul 19.

Abstract

We report a fatal case of community-acquired empyema thoracis and candidemia caused by Candida albicans. The patient responded poorly to human recombinant activated protein C and intravenous fluconazole treatment and died of profound shock with multiple organ failure 8 days after admission.

Publication types

  • Case Reports

MeSH terms

  • Antifungal Agents / therapeutic use
  • Candida albicans / pathogenicity*
  • Candidemia / complications
  • Candidemia / drug therapy
  • Candidemia / microbiology*
  • Community-Acquired Infections / complications
  • Community-Acquired Infections / drug therapy
  • Community-Acquired Infections / microbiology*
  • Empyema / complications
  • Empyema / microbiology*
  • Fluconazole / therapeutic use
  • Follow-Up Studies
  • Humans
  • Intensive Care Units
  • Male
  • Middle Aged
  • Protein C / therapeutic use
  • Recombinant Proteins / therapeutic use
  • Thoracic Cavity / microbiology*
  • Thoracic Cavity / pathology

Substances

  • Antifungal Agents
  • Protein C
  • Recombinant Proteins
  • Fluconazole
  • drotrecogin alfa activated